| |
January 9, 2004
CAMBRIDGE, MA — January 9, 2004 – Momenta Pharmaceuticals,
Inc., a leader in applying advanced technology for complex sugars to the
discovery and development of pharmaceutical products, announced today
that it will present at the upcoming 22nd Annual JP Morgan Healthcare
Conference. Chairman and Chief Executive
Officer Alan L. Crane will provide a corporate overview on Wednesday,
January 14, 2004 at 11:30 a.m. PST at the Westin St. Francis Hotel,
335 Powell Street, San Francisco, California.
About Momenta
Momenta Pharmaceuticals, Inc. is a leader in applying breakthroughs
in understanding the chemistry and biology of complex sugars to the
discovery, development, and commercialization of drug products. In its
short history, Momenta has built a diversified pipeline of product candidates
comprised of novel therapeutics and the application of its technology
to existing products and molecules. Momenta’s proprietary technology
provides a more complete understanding of disease and drug action by
enabling high throughput sequencing, precise chemical structure characterization,
and engineering of complex sugars and glycosylated biomolecules. Founded
in 2001, Momenta is headquartered in Cambridge, MA. Additional information
about Momenta is available on the company’s website, www.momentapharma.com.
###
This press release contains archival information, which should not be
considered current and may no longer be accurate.
|
|
|
